AMRA Overview

  • Founded
  • 2010
  • Status
  • Private
  • Employees
  • 41
  • Latest Deal Type
  • Series C
  • Investors
  • 5

AMRA General Information


Developer of precision medicine technology designed for vital medical decisions. The company's technology automatically produces multiple fats and muscle biomarkers with unrivalled precision and accuracy alongside contextual disease insights in genetics, lifestyle and biology and body composition assessment, enabling doctors to monitor small, clinically relevant changes in fat and muscle volumes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Monitoring Equipment
Primary Office
  • Badhusgatan 5
  • 582 22 Linkoping
  • Sweden
+46 013-16 00 00

AMRA Timeline

Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

AMRA Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series C) 01-Jan-2019 0000 Completed Generating Revenue
4. Later Stage VC 17-Jan-2017 000 0000 Completed Generating Revenue
3. Early Stage VC 27-Jan-2015 00.000 00.000 Completed Startup
2. Early Stage VC 29-Jan-2014 $771K $771K Completed Startup
1. Accelerator/Incubator Completed Startup
To view AMRA’s complete valuation and funding history, request access »

AMRA Executive Team (11)

Name Title Board Seat Contact Info
Eric Converse Chief Executive Officer
Klas Themner Ph.D Co-Chief Financial Officer, Chief Operating Officer & Senior Vice President, Product Management
Magnus Borga Ph.D Co-Founder, Board Member & Co-Chief Technology Officer
Olof Leinhard Ph.D Co-Founder, Chief Scientific Officer, Co-Chief Technology Officer & Board Member
Janne West Ph.D Vice President, Quality Assurance & Regulatory Affairs
You’re viewing 5 of 11 executive team members. Get the full list »

AMRA Board Members (7)

Name Representing Role Since
Kevin John Dean Self Chairman 000 0000
Lars Henriksson Industrifonden Board Member 000 0000
Magnus Borga Ph.D AMRA Co-Founder, Board Member & Co-Chief Technology Officer 000 0000
Patrik Sobocki Ph.D Industrifonden Board Member 000 0000
Søren Moller Ph.D Novo Holdings Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

AMRA Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AMRA Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Novo Holdings Venture Capital Minority 000 0000 000000 0
Pfizer Ventures Corporate Venture Capital Minority 000 0000 000000 0
Industrifonden Venture Capital Minority 000 0000 000000 0
LEAD Incubator Accelerator/Incubator 000 0000 000000 0
SUP46 Accelerator/Incubator Minority 000 0000 000000 0
To view AMRA’s complete investors history, request access »